Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 283
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07001618 | Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer | ||
| NCT00673010 | Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma | ||
| NCT03356535 | Metabolic Signature of Healthy Lifestyle and HCC | ||
| NCT01856296 | A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies | ||
| NCT00346645 | A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer | ||
| NCT00936156 | Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years | ||
| NCT02619565 | Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes | ||
| NCT01414933 | High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents | ||
| NCT02008734 | Randomized Phase II Study to Assess PD 0332991 in Breast Cancer | ||
| NCT00634777 | Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT06007092 | Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer | ||
| NCT03010124 | Prognostic and Predictive Biomarkers in Ovarian Cancers | ||
| NCT01504815 | Adaptive Radiation Treatment for Head and Neck Cancer | ||
| NCT04940325 | Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer | ||
| NCT04567446 | Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach | ||
| NCT06934057 | Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma | ||
| NCT07436312 | Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer | ||
| NCT00544349 | Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery | ||
| NCT06902883 | Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting | ||
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | ||
| NCT03402568 | Alcohol Consumption and Circulating Metabolites | ||
| NCT06402864 | Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma | ||
| NCT07016230 | Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB) | ||
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | ||
| NCT00126269 | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary | ||
| NCT03165292 | Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction | ||
| NCT02516774 | A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers | ||
| NCT01884623 | Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer | ||
| NCT05267912 | Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers | ||
| NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | ||
| NCT03596281 | Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer | ||
| NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | ||
| NCT01837745 | Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? | ||
| NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | ||
| NCT00935675 | Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment | ||
| NCT07082452 | A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction | ||
| NCT01211938 | Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract | ||
| NCT02666625 | Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank | ||
| NCT03703050 | Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) | ||
| NCT01864850 | Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC | ||
| NCT00949039 | Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer | ||
| NCT03609112 | Neurocognitive Risks in Children With Solid Tumors | ||
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | ||
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | ||
| NCT03982173 | Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors | ||
| NCT03351296 | Two Chemotherapy Regimens Plus or Minus Bevacizumab | ||
| NCT02230176 | Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II | ||
| NCT00181051 | Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia | ||
| NCT00359645 | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | ||
| NCT00180830 | Glivec Phase II Pediatric Study |
